Dihua Yu
Dihua Yu
Geverifieerd e-mailadres voor mdanderson.org
Geciteerd door
Geciteerd door
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
Y Nagata, KH Lan, X Zhou, M Tan, FJ Esteva, AA Sahin, KS Klos, P Li, ...
Cancer cell 6 (2), 117-127, 2004
Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer
R Nahta, D Yu, MC Hung, GN Hortobagyi, FJ Esteva
Nature clinical practice Oncology 3 (5), 269-280, 2006
Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth
L Zhang, S Zhang, J Yao, FJ Lowery, Q Zhang, WC Huang, P Li, M Li, ...
Nature 527 (7576), 100-104, 2015
p53 regulates epithelial–mesenchymal transition and stem cell properties through modulating miRNAs
CJ Chang, CH Chao, W Xia, JY Yang, Y Xiong, CW Li, WH Yu, ...
Nature cell biology 13 (3), 317-323, 2011
ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation
JY Yang, CS Zong, W Xia, H Yamaguchi, Q Ding, X Xie, JY Lang, CC Lai, ...
Nature cell biology 10 (2), 138-148, 2008
Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis
YM Li, Y Pan, Y Wei, X Cheng, BP Zhou, M Tan, X Zhou, W Xia, ...
Cancer cell 6 (5), 459-469, 2004
Combating trastuzumab resistance by targeting SRC, a common node downstream of multiple resistance pathways
S Zhang, WC Huang, P Li, H Guo, SB Poh, SW Brady, Y Xiong, LM Tseng, ...
Nature medicine 17 (4), 461-469, 2011
Overexpression of ErbB2 in cancer and ErbB2-targeting strategies
D Yu, MC Hung
Oncogene 19 (53), 6115-6121, 2000
Overexpression of ErbB2 blocks Taxol-induced apoptosis by upregulation of p21Cip1, which inhibits p34Cdc2 kinase
D Yu, T Jing, B Liu, J Yao, M Tan, TJ McDonnell, MC Hung
Molecular cell 2 (5), 581-591, 1998
Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers
X Zhou, M Tan, VS Hawthorne, KS Klos, KH Lan, Y Yang, W Yang, ...
Clinical Cancer Research 10 (20), 6779-6788, 2004
Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity
CW Li, SO Lim, W Xia, HH Lee, LC Chan, CW Kuo, KH Khoo, SS Chang, ...
Nature communications 7 (1), 1-11, 2016
Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A
D Yu, JK Wolf, M Scanlon, JE Price, MC Hung
Cancer research 53 (4), 891-898, 1993
PTEN, PIK3CA, p-AKT, and p-p70S6K status: association with trastuzumab response and survival in patients with HER2-positive metastatic breast cancer
FJ Esteva, H Guo, S Zhang, C Santa-Maria, S Stone, JS Lanchbury, ...
The American journal of pathology 177 (4), 1647-1656, 2010
Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities
M Tan, J Yao, D Yu
Cancer research 57 (6), 1199-1205, 1997
The Skp2-SCF E3 ligase regulates Akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesis
CH Chan, CF Li, WL Yang, Y Gao, SW Lee, Z Feng, HY Huang, KKC Tsai, ...
Cell 149 (5), 1098-1111, 2012
Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression
L Zhang, D Yu, M Hu, S Xiong, A Lang, LM Ellis, RE Pollock
Cancer research 60 (13), 3655-3661, 2000
Fats and fatty oils
A Thomas, B Matthäus, HJ Fiebig
Ullmann's Encyclopedia of Industrial Chemistry, 1-84, 2000
c-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties
D Yu, SS Wang, KM Dulski, CM Tsai, GL Nicolson, MC Hung
Cancer research 54 (12), 3260-3266, 1994
A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas
JD Henson, JA Hannay, SW McCarthy, JA Royds, TR Yeager, ...
Clinical Cancer Research 11 (1), 217-225, 2005
Deubiquitination and stabilization of PD-L1 by CSN5
SO Lim, CW Li, W Xia, JH Cha, LC Chan, Y Wu, SS Chang, WC Lin, ...
Cancer cell 30 (6), 925-939, 2016
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20